**Question:** The peripheral blood lymphoid cells in the described patient were positive for CD19, CD5, CD20, and CD23, and negative for CD79B and FMC-7. The histopathological examination of the lymph node in this patient will most likely exhibit effacement of lymph node architecture by:

**Core Concept:** The described patient presents with a clinical scenario suggestive of B-cell lymphoproliferative disorder. Peripheral blood lymphoid cells are positive for CD19, CD5, CD20, and CD23, and negative for CD79B and FMC-7, which are characteristic immunophenotype of B-cell lymphoproliferative disorders. This combination of markers is typically seen in B-cell chronic lymphocytic leukemia (CLL) and its variants.

**Why the Correct Answer is Right:** The correct answer is D (Lymphoid infiltration), as the histopathological examination of the lymph node in this patient is most likely to demonstrate effacement of lymph node architecture due to infiltration by the abnormal B-cells that are present in the described patient. These cells are involved in the lymphoid infiltration, leading to distortion of the normal architecture of the lymph node.

**Why Each Wrong Option is Incorrect:**

A. Histiocytic infiltration: The patient has B-cell lymphoproliferative disorder and not a histiocytic disorder.
B. T-cell lymphoma: The patient's immunophenotype doesn't support T-cell lymphoma, as the cells express CD19, CD5, CD20, and CD23, which are markers typically expressed in B-cell lymphoproliferative disorders.
C. Reactive lymphoid hyperplasia: The patient has a lymphoproliferative disorder, not a reactive condition. The immunophenotype supports the diagnosis of B-cell lymphoproliferative disorder.
D. Lymphoid infiltration: This is the correct answer as explained above.

**Clinical Pearl:** A comprehensive immunophenotyping of the abnormal lymphocytes is essential in differentiating B-cell lymphoproliferative disorders from reactive lymphoid hyperplasia. B-cell lymphoproliferative disorders express the described immunophenotype, while reactive lymphoid hyperplasia lacks these markers. This helps in narrowing down the differential diagnosis and directing further management strategies.

**Correct Answer Explanation:**

The correct answer is D (Lymphoid infiltration). The histopathological examination of the lymph node in this case indicates infiltration by abnormal B-cells, which are present in this patient with B-cell lymphoproliferative disorder. The immunophenotyping of these cells shows expression of CD19, CD5, CD20, and CD23, which are markers typically expressed in B-cell lymphoproliferative disorders.

**Why the Other Options are Incorrect:**

A. Histiocytic infiltration: This is not the correct answer because the patient has a B-cell lymphoproliferative disorder, not a histiocytic disorder. The immunophenotype of the abnormal lymphocytes in this patient does not support histiocy